Mike Tilton joined Avanir Pharmaceuticals as Chief Commercial Officer in August 2020 to lead Avanir’s commercial operations, including sales and revenue growth, product marketing and Avanir’s go-to-market strategies. Mike brings more than 30 years of experience and expertise as a senior leader within the biopharmaceutical industry with a strong track record for transforming organizational performance through the development and implementation of unique customer-facing models. He most recently served at Syneos Health as Executive Vice President, Commercial Solutions. In addition to Syneos Health, Mike’s career has also included serving Amgen as Vice President of Sales for the Osteoporosis and Cardiovascular business unit, and AstraZeneca Pharmaceuticals where he served for 26 years in positions of increasing responsibility.
Mike earned a Bachelor of Arts in Marketing from Texas State University and has served on boards of for-profit and not-for-profit organizations.